Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Vipoglanstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gesynta Doses First Patient In Vipoglanstat Endometriosis Trial
    Gesynta Doses First Patient In Vipoglanstat Endometriosis Trial

    17 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat-302711075.html

    PR NEWSWIRE
    17 Mar 2026
    Share Share
    Gesynta Pharma Doses First Patient in Endometriosis Trial
    Gesynta Pharma Doses First Patient in Endometriosis Trial

    11 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-11/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat

    PHARMIWEB
    11 Mar 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.